Tuesday, January 13, 2026 1/13/2026

ABCD-USA Consortium: Coordinating Center

Award Number: U24DA041147
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2015
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

ABCD-USA Consortium: Coordinating Center - PROJECT SUMMARY Supplemental funds are requested to continue achieving three key objectives of the ABCD Study: dissemination, resource sharing, and comprehensive genomic analysis. To accomplish this, the ABCD consortium will contract a professional communications vendor to perform the following services: generating engaging and accurate information for different audiences in various forms, developing materials (e.g., flyers, cards, newsletters, infographics), including graphic design; supporting social media, including content creation and managing an interactive forum; foreign language translation of all materials into Spanish to accommodate Spanish monolingual participants and families; providing support for meeting and event logistics, including webinars for families and the general public, while also targeting different research communities; conducting audience research/focus groups (as needed) to guide the development of new assessment elements and acceptability of materials for various groups seeking information about the study results; and implementing retention campaigns through channels such as outreach and social media (as needed) to bolster retention. Additional funds are also necessary for the continued support of biorepository functions currently provided by the Altman Clinical and Translational Research Institute (ACTRI) for maintaining a Biobank for salivary fluid samples and shed deciduous teeth contributed by ABCD participants. Funding is requested for: ACTRI staff effort; lab supplies, including tubes for aliquoting, freezer boxes, and biosafety materials; shipping of the samples to ACTRI; secure storage for saliva samples, housed in three to four secure, monitored freezers, and secure dry storage for teeth; a dedicated cold-empty freezer for emergency use; daily physical monitoring of all freezers, 24-hour electronic monitoring, and fault notification capabilities; a license fee for FreezerWorks software for sample tracking, management, and freezer inventory; and the development of an API to allow ACTRI to access the NBDC Portal. Funding is also requested to replace centrifuges at all sites with new refrigerated centrifuges to reduce the incidence of poor quality when aliquoting serum samples. Lastly, funding is also requested for whole genome sequencing and quality control of sequencing data for remaining unsequenced participants in the cohort, as well as confirmatory testing (through CLIA-certified service) and provision of genetic counseling to individuals who meet criteria for pathogenic medically actionable secondary findings. Genetic counseling will also be offered to individuals who may need additional information to decide whether to consent to receive their results.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	11	10/1/2025	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $7,147,304 )
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	005	11	9/9/2025	SUPPLEMENT FOR EXPANSION	$0
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	006	11	9/26/2025	NON-COMPETING CONTINUATION	$0
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	11	4/18/2025	NON-COMPETING CONTINUATION	$0
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	11	4/11/2025	NON-COMPETING CONTINUATION	$3,560,221
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	11	7/8/2025	SUPPLEMENT FOR EXPANSION	$3,387,083
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	11	7/16/2025	NON-COMPETING CONTINUATION	$200,000
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	004	10	9/8/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $7,147,304

Issue Date FY: 2024 ( Subtotal = $3,954,817 )
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	10	5/30/2024	NON-COMPETING CONTINUATION	$200,000
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	004	10	8/22/2024	NON-COMPETING CONTINUATION	$0
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	10	4/23/2024	NON-COMPETING CONTINUATION	$3,364,670
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	10	7/17/2024	NON-COMPETING CONTINUATION	$0
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	10	7/25/2024	NON-COMPETING CONTINUATION	$390,147
2024	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	005	9	9/13/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,954,817

Issue Date FY: 2023 ( Subtotal = $4,342,176 )
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	005	9	4/10/2023	SUPPLEMENT FOR EXPANSION	$200,000
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	004	9	4/7/2023	SUPPLEMENT FOR EXPANSION	$200,000
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	9	3/30/2023	NON-COMPETING CONTINUATION	$3,179,748
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	007	9	6/28/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	008	9	6/30/2023	SUPPLEMENT FOR EXPANSION	$765,000
2023	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	8	1/26/2023	SUPPLEMENT FOR EXPANSION	$0
2023	2019	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	006	5	5/8/2023	NON-COMPETING CONTINUATION	$0
2023	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	4	12/16/2022	NON-COMPETING CONTINUATION	$0
2023	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	4	2/2/2023	NON-COMPETING CONTINUATION	-$2,572
														Subtotal = $4,342,176

Issue Date FY: 2022 ( Subtotal = $4,144,035 )
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	004	8	8/29/2022	NON-COMPETING CONTINUATION	$0
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	8	5/6/2022	SUPPLEMENT FOR EXPANSION	$200,000
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	8	3/24/2022	NON-COMPETING CONTINUATION	$3,544,035
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	8	5/23/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	8	5/16/2022	SUPPLEMENT FOR EXPANSION	$400,000
														Subtotal = $4,144,035

Issue Date FY: 2021 ( Subtotal = $4,559,103 )
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	009	7	7/1/2021	SUPPLEMENT FOR EXPANSION	$200,000
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	006	7	4/15/2021	NON-COMPETING CONTINUATION	$3,705,028
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	011	7	9/16/2021	NON-COMPETING CONTINUATION	$0
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	008	7	6/4/2021	SUPPLEMENT FOR EXPANSION	$654,075
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	010	7	9/15/2021	NON-COMPETING CONTINUATION	$0
2021	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	6	12/21/2020	COMPETING CONTINUATION	$0
2021	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	007	6	5/5/2021	COMPETING CONTINUATION	$4,051,162
2021	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	6	12/14/2020	COMPETING CONTINUATION	$0
2021	2019	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	5	4/13/2021	NON-COMPETING CONTINUATION	-$2,874,097
2021	2019	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	005	4	4/13/2021	SUPPLEMENT FOR EXPANSION	-$250,000
2021	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	004	4	4/13/2021	SUPPLEMENT FOR EXPANSION	-$601,121
2021	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	4	4/13/2021	SUPPLEMENT FOR EXPANSION	-$325,944
														Subtotal = $4,559,103

Issue Date FY: 2020 ( Subtotal = $5,122,833 ) (Continued on the next page)
2020	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	006	6	8/18/2020	SUPPLEMENT FOR EXPANSION	$650,000
2020	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	6	4/14/2020	COMPETING CONTINUATION	$2,818,830
2020	2020	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	008	6	9/15/2020	SUPPLEMENT FOR EXPANSION	$157,487
Grand Total All Awards = $45,263,086

Page 1 of 2 (75 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

ABCD-USA Consortium: Coordinating Center

Award Number: U24DA041147

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2015

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer